
Open Offer17 Jun 2026, 07:00 pm
Novartis India Open Offer: Zero Shares Tendered So Far
AI Summary
Axis Capital Ltd, the Manager to the Open Offer for Novartis India Limited, has disclosed that as of June 17, 2026, zero equity shares have been tendered by public shareholders. This applies to shares submitted both in dematerialized form to the Open Offer Escrow Demat Account and in physical form to the Registrar. The Open Offer, initiated by WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners, aims to acquire up to 26% of the company's voting share capital. The disclosure clarifies that the number of tendered shares is subject to validation and may differ from the final accepted shares.
Key Highlights
- Zero equity shares tendered in Novartis India Open Offer as of June 17, 2026.
- Disclosure covers both dematerialized and physical share submissions.
- Open Offer aims to acquire 26% of Novartis India's voting share capital.
- Tendered shares are subject to validation and verification.
- Acquirers include WaveRise Investments, ChrysCapital, and Two Infinity Partners.
Price Impact
More from NOVARTIND